What is ANIK's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.26B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for ANIK?

P/E (TTM) is n/a and 52-week range is $8.67 to $22.88 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s ANIK figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for ANIK?

The company profile lists revenue (TTM) near $118M, net income (TTM) near $-370M, EPS (TTM) near $-0.27 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Anika Therapeutics Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Bedford, Massachusetts, US, 13.4M shares outstanding, ISIN US0352551081 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

Anika Therapeutics Inc

$ANIK

Health Care · Biotechnology

IR Run Scenarios

$19.58

+1.82%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. The company is headquartered in Bedford, Massachusetts and currently employs 235 full-time employees. The firm is leveraging its core expertise in hyaluronic acid and implant solutions. The company partners with clinicians to provide minimally invasive products that restore active living for people around the world. The company is developing, manufacturing and commercializing products on its hyaluronic acid (HA) technology platform. The company is focused on spaces within orthopedics, including osteoarthritis pain management and regenerative solutions, and its products are delivered in key sites of care, including ambulatory surgery centers. Its products include OA Pain Management, Regenerative Solutions, and others. The OA Pain Management product family consists of Cingal, Monovisc, Orthovisc, Orthovisc mini and Orthovisc-T. Its Regenerative Solutions include Integrity, Hyalofast, Tactoset and NanoFx.

Employees

235

Website

anika.com/

IPO

1985-05-16

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)